Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
GJGordon John Sampson RustinIVIgnace VergoteEAElizabeth A. EisenhauerÉPÉric Pujade-LauraineMQMichael Quinn
Mount Vernon Hospital · KU Leuven · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
616
total citations
- FWCI
- 26.32
- Percentile
- 100%
- References
- 8
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Medicine
- Clinical trial
- Response Evaluation Criteria in Solid Tumors
- Cancer
- Gynecologic cancer
- Disease
- Oncology
- Ovarian cancer
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.